Lubicz Boris, Leclerc Xavier, Gauvrit Jean-Yves, Lejeune Jean-Paul, Pruvo Jean-Pierre
Department of Neuroradiology, Roger Salengro Hospital, University Hospital of Lille, Lille, France.
Neurosurgery. 2004 Aug;55(2):316-23; discussion 323-6. doi: 10.1227/01.neu.0000129477.15636.ae.
To report long-term imaging follow-up and clinical outcome of 13 patients with a giant vertebrobasilar aneurysm treated by parent artery occlusion (PAO).
From 1994 to 2000, 13 consecutive patients with a giant vertebrobasilar aneurysm were treated by PAO. Symptoms were related to mass effect in nine patients and to a subarachnoid hemorrhage in four. Endovascular treatment consisted of aneurysm trapping in nine patients and occlusion of one or both vertebral arteries in four. We assessed the clinical outcome and imaging findings in all patients during a 28-month period.
Endovascular treatment resulted in clinical improvements in eight patients, worsening of symptoms in four, and death in one. One woman with a ruptured vertebral aneurysm died from a rebleeding after PAO without trapping. One man developed a brainstem infarction after lower basilar artery occlusion and incurred hemiparesis. In three patients, symptoms of mass effect increased after the procedure. Long-term follow-up revealed good or excellent clinical outcome in all patients and a sharp decrease in size of the thrombosed aneurysm in nine patients. One basilar aneurysm recanalized despite selective coiling and subsequent bilateral vertebral artery occlusion; one vertebral aneurysm and one basilar aneurysm did not decrease in size despite complete occlusion.
Giant vertebrobasilar aneurysms are rare and challenging lesions for both neurosurgeons and neurointerventionalists. Their treatment by endovascular PAO remains safe and effective. Early clinical worsening may be observed, but long-term follow-up shows good or excellent results in most patients. This treatment can be carried out with minimal morbidity and mortality using clinical and angiographic monitoring.
报告13例经母动脉闭塞术(PAO)治疗的巨大椎基底动脉瘤患者的长期影像学随访及临床结果。
1994年至2000年,连续13例巨大椎基底动脉瘤患者接受了PAO治疗。9例患者的症状与占位效应有关,4例与蛛网膜下腔出血有关。血管内治疗包括9例患者的动脉瘤夹闭术和4例患者的一侧或双侧椎动脉闭塞术。我们在28个月的时间里评估了所有患者的临床结果和影像学表现。
血管内治疗使8例患者临床症状改善,4例症状恶化,1例死亡。1例椎动脉动脉瘤破裂的女性在未夹闭的PAO术后死于再出血。1例男性在基底动脉下段闭塞后发生脑干梗死并出现偏瘫。3例患者术后占位效应症状加重。长期随访显示所有患者临床结果良好或极佳,9例患者血栓形成的动脉瘤大小急剧减小。1例基底动脉瘤尽管进行了选择性弹簧圈栓塞及随后的双侧椎动脉闭塞仍发生再通;1例椎动脉动脉瘤和1例基底动脉瘤尽管完全闭塞但大小未减小。
巨大椎基底动脉瘤对神经外科医生和神经介入医生来说都是罕见且具有挑战性的病变。通过血管内PAO治疗仍然安全有效。可能会观察到早期临床症状恶化,但长期随访显示大多数患者结果良好或极佳。使用临床和血管造影监测,这种治疗可以在最低的发病率和死亡率下进行。